Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ray, S.G.
Right arrow Articles by Dargie, H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ray, S.G.
Right arrow Articles by Dargie, H.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Importance of RAA System and the Treatment of Patients with ACE Inhibition After Myocardial Infarction

S.G. Ray

Department of Cardiology and MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland

H.M. McAlpine

Department of Cardiology and MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland

J.J. Morton

Department of Cardiology and MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland

B. Leckie

Department of Cardiology and MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland

H.J. Dargie

Department of Cardiology and MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland

There is activation of the renin angiotensin system after both complicated and uncomplicated myocardial infarction. Angiotensin II increases myocardial oxy gen consumption whilst reducing coronary flow and is also directly toxic to the myocardium. Angiotensin converting enzyme inhibitors produce beneficial haemodynamic and neuroendocrine changes in patients with acute left ventricular failure, and may have a role in selected patients with cardiogenic shock. There is evidence to suggest that they might prevent the development of late cardiac failure by limiting the extent of post infarction ventricular dilation. Further research is necessary to define their role in the treatment of acute myocardial infarction.

Angiology, Vol. 42, No. 4, 268-272 (1991)
DOI: 10.1177/000331979104200402
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement